Warning: Javascript must be enabled within your browser's settings for this site to function properly.

Your browser appears to be out of date, and is not supported by this site. For the best experience, we recommend that you upgrade to a more modern browser. You can find a list of modern browsers from www.browsehappy.com.

We use technical and analytics cookies data to ensure that we give you the best experience on our website. For more information visit our Privacy Page.

BWXT $   $  
As of . Minimum 20 minute delay.

Contract Manufacturing

BWXT Medical is a trusted partner for developing and manufacturing services for biotechnology and pharmaceutical companies around the world. Our customers and partners have come to rely on us to ensure their clinical, commercial, and patient needs are being met by:

  • Providing pre-clinical research materials
  • Offering scalable manufacturing volumes that support the smallest clinical trials to large-scale, commercial endeavors
  • Developing and manufacturing radiochemicals and active pharmaceutical ingredients (APIs) suited to your needs
  • Developing and manufacturing radiopharmaceuticals in our 80,000 square feet cGMP/GLP manufacturing facility
  • Exemplary record of regulatory compliance with key regulatory agencies including the FDA, Health Canada, US Nuclear Regulatory Commission (NRC), Canadian Nuclear Safety Commission (CNSC) and other similar agencies around the world
  • Robust logistics experience for global distribution of nuclear medicine products

Our rich history of contract manufacturing radiopharmaceutical innovations include:

  • An innovative non-Hodgkin’s lymphoma therapeutic using Iodine-131
  • Y-90 Chloride Sterile Solution used to radiolabel a radiopharmaceutical to treat non-Hodgkin’s lymphoma
  • Iodine-125 Solution used in brachytherapy sources for therapeutic treatment
  • Rubidium-82 generators for cardiac PET imaging
  • P-32 Coated Stents used for coronary artery disease
  • Iodine-131 MIBG for imaging and treating certain types of neuroendocrine tumors
  • Neuradiab for treatment of recurrent glioblastoma multiforme

For more information on our contract manufacturing and development services please contact our Head of Commercial & Business Development, Richard Caligaris.

TheraSphereTM
TheraSphere™

BWXT is under contract by Boston Scientific Corporation to manufacture TheraSphereTM, an implantable Class III medical device used to treat liver cancer, at our Ottawa, Ontario facility.

BWXT and Boston Scientific work together to address global TheraSphere Demand’.